Pre-order Enquiry
Request Free Sample
Global Radiopharmaceuticals Market Growth 2019-2024
SKU ID : LPI-13814347 | Publishing Date : 04-Feb-2019 | No. of pages : 158
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
According to this study, over the next five years the Radiopharmaceuticals market will register a 7.8% CAGR in terms of revenue, the global market size will reach US$ 7130 million by 2024, from US$ 4900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study considers the Radiopharmaceuticals value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
According to this study, over the next five years the Radiopharmaceuticals market will register a 7.8% CAGR in terms of revenue, the global market size will reach US$ 7130 million by 2024, from US$ 4900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study considers the Radiopharmaceuticals value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
